Identification and utility exploration of a highly potent and long acting bullfrog GLP 1 analogue in GLP 1 and amylin combination therapy ScienceDirect Effects of GLP 1 (blue arrows), glucagon (red arrows) and GIP (green Download Scientific Diagram Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit The Influence of Glucagon like Peptide 1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition GIP mediates the incretin effect and glucose tolerance by dual actions on cells and cells Science Advances Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination